Joseph Romano
Founder at Lucid Psycheceuticals, Inc.
Profile
Joseph L.
Romano is the founder of Lucid Psycheceuticals, Inc. and Romano Law.
Prior to this, he served as an Independent Director at FSD Pharma, Inc. He completed his undergraduate degree at Osgoode Hall Law School.
Joseph Romano active positions
Companies | Position | Start |
---|---|---|
Lucid Psycheceuticals, Inc.
Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Founder | - |
Romano Law | Founder | - |
Former positions of Joseph Romano
Companies | Position | End |
---|---|---|
FSD PHARMA INC. | Director/Board Member | - |
Training of Joseph Romano
Osgoode Hall Law School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FSD PHARMA INC. | Health Technology |
Private companies | 2 |
---|---|
Lucid Psycheceuticals, Inc.
Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Health Services |
Romano Law |
- Stock Market
- Insiders
- Joseph Romano